Suppr超能文献

羊水干细胞及其在基于细胞的组织再生中的应用。

Amniotic fluid stem cells and their application in cell-based tissue regeneration.

作者信息

Baghaban Eslaminejad Mohamadreza, Jahangir Shahrbanoo

机构信息

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

出版信息

Int J Fertil Steril. 2012 Oct;6(3):147-56. Epub 2012 Dec 17.

Abstract

Advances in stem cell biotechnology hold great promise in the field of tissue engineering and regenerative medicine. Of interest are marrow mesenchymal stem cells (MSCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs). In addition, amniotic fluid stem cells (AFSCs) have attracted attention as a viable choice following the search for an alternative stem cell source. Investigators are interested in these cells because they come from the amniotic fluid that is routinely discarded after birth. There have been multiple investigations conducted worldwide in an attempt to better understand AF-SCs in terms of their potential use in regenerative medicine. In this review we give a brief introduction of amniotic fluid followed by a description of the cells present within this fluid. Their history related to stem cell discovery in the amniotic fluid as well as the main characteristics of AF-SCs are discussed. Finally, we elaborate on the potential for these cells to promote regeneration of various tissue defects, including fetal tissue, the nervous system, heart, lungs, kidneys, bones, and cartilage.

摘要

干细胞生物技术的进展在组织工程和再生医学领域有着巨大的前景。骨髓间充质干细胞(MSC)、胚胎干细胞(ESC)和诱导多能干细胞(iPSC)备受关注。此外,羊水干细胞(AFSC)作为一种可行的替代干细胞来源,在寻找替代干细胞来源后也引起了人们的关注。研究人员对这些细胞感兴趣,因为它们来自出生后通常被丢弃的羊水。世界各地已经进行了多项研究,试图更好地了解羊水干细胞在再生医学中的潜在用途。在这篇综述中,我们首先简要介绍羊水,然后描述羊水中存在的细胞。讨论了它们与羊水中干细胞发现相关的历史以及羊水干细胞的主要特征。最后,我们详细阐述了这些细胞促进各种组织缺损再生的潜力,包括胎儿组织、神经系统、心脏、肺、肾脏、骨骼和软骨。

相似文献

1
Amniotic fluid stem cells and their application in cell-based tissue regeneration.
Int J Fertil Steril. 2012 Oct;6(3):147-56. Epub 2012 Dec 17.
2
A Mini Overview of Isolation, Characterization and Application of Amniotic Fluid Stem Cells.
Int J Stem Cells. 2015 Nov;8(2):115-20. doi: 10.15283/ijsc.2015.8.2.115.
3
Osteogenic Differentiation Potential of Human Bone Marrow and Amniotic Fluid-Derived Mesenchymal Stem Cells in Vitro & in Vivo.
Open Access Maced J Med Sci. 2019 Feb 14;7(4):507-515. doi: 10.3889/oamjms.2019.124. eCollection 2019 Feb 28.
6
[Research development of amniotic fluid-derived stem cells in regenerative medicine].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Oct;27(10):1262-6.
7
Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential.
World J Stem Cells. 2015 May 26;7(4):681-90. doi: 10.4252/wjsc.v7.i4.681.
9
Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.
Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:30-44. doi: 10.1016/j.bpobgyn.2015.07.006. Epub 2015 Sep 10.
10
Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.
Stem Cells Transl Med. 2016 Dec;5(12):1595-1606. doi: 10.5966/sctm.2016-0016. Epub 2016 Jul 27.

引用本文的文献

1
Amniotic fluid: its role in fetal development and beyond.
J Perinatol. 2025 May 8. doi: 10.1038/s41372-025-02313-1.
2
Stem cell therapy in pulmonary hypertension: current practice and future opportunities.
Eur Respir Rev. 2023 Sep 27;32(169). doi: 10.1183/16000617.0112-2023. Print 2023 Sep 30.
3
Necrotizing enterocolitis: recent advances in treatment with translational potential.
Pediatr Surg Int. 2023 May 29;39(1):205. doi: 10.1007/s00383-023-05476-0.
5
Amniotic fluid characteristics and its application in stem cell therapy: A review.
Int J Reprod Biomed. 2022 Sep 6;20(8):627-643. doi: 10.18502/ijrm.v20i8.11752. eCollection 2022 Aug.
7
Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells.
PLoS One. 2021 Dec 2;16(12):e0260522. doi: 10.1371/journal.pone.0260522. eCollection 2021.
9
Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin.
Stem Cell Res Ther. 2021 Feb 12;12(1):126. doi: 10.1186/s13287-021-02196-x.

本文引用的文献

1
Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells.
Tissue Eng Part A. 2012 May;18(9-10):1006-13. doi: 10.1089/ten.TEA.2011.0542. Epub 2012 Jan 26.
2
Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix.
Tissue Eng Part A. 2011 Nov;17(21-22):2833-43. doi: 10.1089/ten.tea.2011.0062. Epub 2011 Aug 24.
5
Amniotic fluid-derived mesenchymal stem cells lead to bone differentiation when cocultured with dental pulp stem cells.
Tissue Eng Part A. 2011 Mar;17(5-6):645-53. doi: 10.1089/ten.TEA.2010.0340. Epub 2010 Nov 22.
9
Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies.
Tissue Eng Part A. 2010 Jun;16(6):1925-36. doi: 10.1089/ten.TEA.2009.0728.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验